RxDoctor Payments Data

Ravi Singh, MD

Psychiatry · Murfreesboro, TNNPI 1922116649

Payments from drug & device makers

$6,038in general payments, 2019–2025

Across 43 payments — averaging $140.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$5K
  • Avanir Pharmaceuticals, Inc.$225
  • Otsuka America Pharmaceutical, Inc.$114
  • Portola Pharmaceuticals, LLC$95
  • Genentech USA, Inc.$92
  • Vanda Pharmaceuticals Inc.$81
  • plus $86 from 2 others

What the payments were for

  • Consulting fees$5,03583%
  • Food & beverage$1,00317%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,038 in reported general payments places this provider in the 85th percentile of 503 psychiatry providers in Tennessee.

See all psychiatry providers in Tennessee

Medicare billing

Part B allowed, 2024
$93,400
Medicare patients
145
Services billed
1,374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$94,495
RexultiBrexpiprazole21$33,314
XifaxanRifaximin16$12,949
Divalproex Sodium70$4,030
Quetiapine Fumarate202$3,208
Donepezil Hcl225$2,197
Memantine Hcl66$1,958
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,884
Aripiprazole37$1,699
Mirtazapine77$1,311
Sertraline Hcl115$1,117
Memantine Hcl ErMemantine Hcl12$1,039
Trazodone Hcl122$990
Vilazodone Hcl13$936
RivastigmineRivastigmine Tartrate13$915

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$114$33,31421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 503 psychiatry providers in Tennessee.

Other psychiatry in Murfreesboro

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →